Cerca

Romagnoli Micaela

 Dott.ssa Micaela Romagnoli

Micaela Romagnoli


Micaela Romagnoli, MD, PhD

Laurea in Medicina e Chirurgia (Università degli Studi di Ferrara)

Specializzazione in Malattie dell’Apparato Respiratorio (Università degli Studi di Ferrara)

Dottorato di Ricerca in Fisiopatologia Respiratoria (Università degli Studi di Parma)

Assegno di Ricerca (Università degli Studi di Modena e Reggio Emilia)

Dirigente Medico I° Livello, Pneumologia Interventistica
Ospedale G.B. Morgagni - L. Pierantoni
Via Forlanini n°34 - Forlì
Telefono: ( 39) 0543-735042       
Fax:  ( 39) 0543-735039
E-mail:  m.romagnoli@ausl.fo.it


Stage all’estero:

  • 1996-1997: Clinique des Maladies Respiratoires – Allergologie, Centre  Hospitalier Universitaire (CHU), Hopital Arnaud de Villeneuve, Université de Montpellier, Unité INSERM 454, Montpellier, France.
  • 2004: Clinique des Maladies Respiratoires, CH Sud-Réunion, Saint Pierre (La Réunion).
  • 2008: Pulmonology Department, LUMC, Leiden, The Netherlands
  • 2011: Zentrum für Pneumologie und Thoraxchirurgie, Krankenhaus Grosshansdorf, Hamburg, Germany
Interessi Clinici:

• Interstiziopatie polmonari - Tumore del polmone -Endoscopia toracica - Asma bronchiale e Broncopneumopatia cronica ostruttiva (BPCO)

Campi di Ricerca:

• Polmonite interstiziale non-specifica (NSIP): NSIP idiopatica e NSIP associata a connettiviti sistemiche.

• Danno polmonare indotto da farmaci (drug-induced lung disease).
• Endoscopia endobronchiale (EBUS/EUS) nella diagnosi e staging del tumore del polmone. 
 

PUBBLICAZIONI SCIENTIFICHE SU RIVISTE PUBMED INDEXED:  

 
1.      Ulivi P, Romagnoli M, Chiodini E, Casoni GL, Capelli L, Gurioli C, Zoli W, Paragoni L, Dubini A, Tesei A, Amadori D, Poletti V. Assessment of EGFR and K-ras mutations in Fixed and Fresh Specimens from Transesophageal Ultrasound-Guided Fine Needle Aspiration (EUS-FNA) in Non-Small-Cell Lung Cancer (NSCLC) patients. Intern J Oncol 2012, in press.
 
2.      Margaritopoulos G, Romagnoli M, Poletti V, Siafakas N, Wells A, Antoniou K. Recent advances in pathogenesis and clinical evaluation of pulmonary fibrosis. Eur Respi Rev 2012, in press.
 
3.      Romagnoli M, Nannini C, Piciucchi S, Girelli F, Gurioli C, Casoni GL, Ravaglia C, Tomassetti S, Gurioli Ch, Gavelli G, Carloni A, Dubini A, Cantini F, Chilosi M, Poletti V. Idiopathic NSIP: an Interstitial Lung Disease Associated with Autoimmune Disorders?       Eur Respir J 2011;38:384-91. Epub 2011 Jan 27. http://www.ncbi.nlm.nih.gov/pubmed/21273390
 
4.      S. Piciucchi, M. Romagnoli, M. Chilosi, C. Bigliazzi, A. Dubini, B. Beomonte Zobel, G. Gavelli, A. Carloni, V. Poletti. Prospective evaluation of drug-induced lung toxicity with high-resolution CT and transbronchial biopsy. Radiol Med. 2011 Mar;116(2):246-263. Epub 2010 Dec 3. http://www.ncbi.nlm.nih.gov/pubmed/21311994
 
5.      Casoni GL, Chilosi M, Romagnoli M, Tomassetti S, Poletti V. Another “chance” for interferon gamma 1b? Sarcoidosis Vasc Diffuse Lung Dis. 2011 Jul;28(1):79-80.
 
6.      Casoni GL, Cordeiro CR Jr, Tomassetti S, Romagnoli M, Chilosi M, Cancellieri A, Gurioli C, Poletti V. The transbonchial lung biopsy for diagnosis of diffuse parenchymal lung disease; Pro. Rev Port Pneumol 2011, Jun 28.
 
7.      Poletti V, Casoni G, Ravaglia C, Romagnoli M, Tomassetti S. Bronchoalveolar lavage. Technical notes. Monaldi Arch Chest Dis. 2011 Mar;75(1):42-3.
 
 
 
10. Casoni GL, Ulivi P, Mercatali L, Chilosi M, Tomassetti S, Romagnoli M, Ravaglia C, Gurioli C, Gurioli C, Zoli W, Silvestrini R, Poletti V. Increased levels of free circulating DNA in patients with idiopathic pulmonary fibrosis. Int J Biol Markers 2010;25:229-235. http://www.ncbi.nlm.nih.gov/pubmed/21161945
 
11. Marco Contoli, Simonetta Baraldo, Brunilda Marku, Paolo Casolari, John A. Marwick, Graziella Turato, Micaela Romagnoli, Gaetano Caramori, Marina Saetta, Leonardo M Fabbri, Alberto Papi. Fixed Airflow Obstruction due to Asthma or Chronic Obstructive Pulmonary Disease: 5-year follow-up. J Allergy Clin Immunol 2010 Apr;125(4):830-7. Epub 2010 Mar 15.2. http://www.ncbi.nlm.nih.gov/pubmed/20227753
 
12. Carlo Gurioli, Claudia Ravaglia, Micaela Romagnoli, Gianluca Casoni, Sara Tomassetti, Oriana Nanni, Venerino Poletti. EBUS-TBNA in mediastinal/hilar lymphadenopathies and/or masses: an Italian case series. Clin Respir J. 2011 Apr 11. doi: 10.1111/j.1752-699X.2010.00232.x.
 
13. Romagnoli M, Gurioli C, Casoni GL, Poletti V. Surgical lung biospy in the diagnosis of idiopathic NSIP: do we really always need it in the initial approach? Am J Respir Crit Care Med 2009;179(11):1071. http://www.ncbi.nlm.nih.gov/pubmed/19458271
 
14. Micaela Romagnoli, Venerino Poletti. “Update on non-specific interstitial pneumonia (NSIP): a pattern, a clinical entity or different phenotypes? Surgical or bronchoscopic diagnosis?”. Recenti Prog Med. 2009;100(12):531-4. http://www.ncbi.nlm.nih.gov/pubmed/20178304
 
15. Micaela Romagnoli, Venerino Poletti. Multifocal fibrosclerosis with lung, mediastinal, pancreatic and retroperitoneal involvement in a 58-year-old man. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 2009;26 (1):73-75. http://www.ncbi.nlm.nih.gov/pubmed/19960792
 
16. Romagnoli M, Bigliazzi C, Casoni GL, Chilosi M, Carloni A, Dubini A, Gurioli Ch, Tomassetti S, Gurioli C, Poletti V. "The role of transbronchial lung biopsy for the diagnosis of diffuse drug-induced lung disease: a case series of 44 patients". Sarcoidosis, Vasculitis and Diffuse Lung Diseases, 2008;25:36-46. http://www.ncbi.nlm.nih.gov/pubmed/19070259
 
17. Casoni G, Gurioli C, Romagnoli M, Poletti V. Diagnosis of pulmonary thromboembolism with endobronchial ultrasound. Eur Respir Journal 2008 Nov;32(5):1416-1417. http://www.ncbi.nlm.nih.gov/pubmed/18978147
 
18. Micaela Romagnoli, Gaetano Caramori, Fausto Braccioni, Franco Ravenna, Esther Barreiro, Nikolaos Siafakas, Antonio M Vignola, Pascal Chanez, Leonardo M Fabbri, Alberto Papi, and the ENFUMOSA Study Group. Near-Fatal Asthma phenotype in the ENFUMOSA Cohort. Clin Exp Allergy. 2007 Apr;37(4):552-7. http://www.ncbi.nlm.nih.gov/pubmed/17430352
 
19. Romagnoli M, Dell'Orso D, Lorenzi C, Crisafulli E, Costi S, Lugli D, Clini EM. "Repeated Pulmonary Rehabilitation in Severe and Disabled COPD Patients". Respiration 2006;73:769-76. Epub 2006 Apr 21. http://www.ncbi.nlm.nih.gov/pubmed/16636528
 
20. Papi A, Bellettato CM, Braccioni F, Romagnoli M, Casolari P, Caramori G, Fabbri LM, Johnston SL. "Infections and airway inflammation in chronic obstructive pulmonary disease severe exacerbations". Am J Respir Crit Care Med. 2006;15;173(10):1114-21. http://www.ncbi.nlm.nih.gov/pubmed/16484677
 
21. Clini EM, Romagnoli M. "Inpatient pulmonary rehabilitation: does it make sense?" Chron Respir Dis. 2005;2(1):43-6. http://www.ncbi.nlm.nih.gov/pubmed/16279748
 
22. Clini E, Costi S, Romagnoli M, Florini F. "Rehabilitation of COPD patients: which training modality". Monaldi Arch Chest Dis. 2004;61(3):167-73. http://www.ncbi.nlm.nih.gov/pubmed/15679011
 
23. Rossi G, Florini F, Romagnoli M, Bellantone T, Lucic S, Lugli D, Clini E. "Length and clinical effectiveness of pulmonary rehabilitation in outpatients with chronic airway obstruction". Chest. 2005 Jan;127(1):105-9. http://www.ncbi.nlm.nih.gov/pubmed/15653969
 
24. Romagnoli M, Fabbri LM. "Chronic obstructive pulmonary disease: definition and classification of severity". Ann Ist Super Sanita. 2003;39(4):461-6. http://www.ncbi.nlm.nih.gov/pubmed/15098568
 
25. Fabbri LM, Romagnoli M, Cossi S, Grassi V. "Chronic obstructive pulmonary disease: brief review". Ann Ital Med Int. 2003 Oct-Dec;18(4):219-30. http://www.ncbi.nlm.nih.gov/pubmed/14971710.
 
26. Caramori G, Romagnoli M, Casolari P, Bellettato C, Casoni G, Boschetto P, Chung KF, Barnes PJ, Adcock IM, Ciaccia A, Fabbri LM, Papi A. "Nuclear localisation of p65 in sputum macrophages but not in sputum neutrophils during COPD exacerbations". Thorax. 2003;58(4):348-51. http://www.ncbi.nlm.nih.gov/pubmed/12668802
 
27. Fabbri LM, Romagnoli M, Corbetta L, Casoni G, Busljetic K, Turato G, Ligabue G, Ciaccia A, Saetta M, Papi A. "Differences in airway inflammation in patients with fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease". Am J Respir Crit Care Med. 2003;167(3):418-24. http://www.ncbi.nlm.nih.gov/pubmed/12426229
 
28. Romagnoli M, Vachier I, Tarodo de la Fuente P, Meziane H, Chavis C, Bousquet J, Godard P, Chanez P. "Eosinophilic inflammation in sputum of poorly controlled asthmatics". Eur Respir J. 2002;20(6):1370-7. http://www.ncbi.nlm.nih.gov/pubmed/12503691
 
29. Romagnoli M, Fabbri LM. "Mild asthma". N Engl J Med. 2002 Apr 25;346(17):1335-6; author reply 1335-6. http://www.ncbi.nlm.nih.gov/pubmed/11973859.
 
30. Papi A, Romagnoli M, Baraldo S, Braccioni F, Guzzinati I, Saetta M, Ciaccia A, Fabbri LM. "Partial reversibility of airflow limitation and increased exhaled NO and sputum eosinophilia in chronic obstructive pulmonary disease". Am J Respir Crit Care Med. 2000;162(5):1773-7. http://www.ncbi.nlm.nih.gov/pubmed/11069811
 
31. Tarodo de la Fuente P, Romagnoli M, Carlsson L, Godard P, Bousquet J, Chanez P. "Eosinophilic inflammation assessed by induced sputum in corticosteroid-dependent asthma". Respir Med. 1999;93(3):183-9. http://www.ncbi.nlm.nih.gov/pubmed/10464876.,
 
32. Romagnoli M, Vachier I, Vignola AM, Godard P, Bousquet J, Chanez P. "Safety and cellular assessment of bronchial brushing in airway diseases". Respir Med. 1999 Jul;93(7):461-6.http://www.ncbi.nlm.nih.gov/pubmed/10464832.
 
33. De la Fuente PT, Romagnoli M, Godard P, Bousquet J, Chanez P. "Safety of inducing sputum in patients with asthma of varying severity". Am J Respir Crit Care Med. 1998;157(4 Pt 1):1127-30. http://www.ncbi.nlm.nih.gov/pubmed/9563729.,
 
34. Fugagnoli A, Castelletti ML, Caramori G, Romagnoli M, Fabbri LM, Ciaccia A. "Subcutaneous emphysema of the chest wall: a case with unusual presentation". Monaldi Arch Chest Dis. 1997;52(5):447-9.http://www.ncbi.nlm.nih.gov/pubmed/9510664
 
35. Romagnoli M, Mourad G, Serre I, Senac JP, Paradis L, Godard P, Chanez P. "Diffuse pulmonary calcinosis without calcium metabolism abnormalities in a renal transplant recipient". Eur Respir J. 1997;10(4):958-60.  http://www.ncbi.nlm.nih.gov/pubmed/9150342
 
 

PUBBLICAZIONI IN RIVISTE NON ELENCATE NEI CURRENT CONTENTS 

1.      Fabbri L, Cremona G, Caramori G, Piattella M, Romagnoli M, Beghè B, Panella GL, Ciaccia A. La scoperta dell’ossido nitrico endogeno ha aperto nuove prospettive terapeutiche nella patologia polmonare dell’adulto? Rassegna di Patologia dell’Apparato Respiratorio 1996;11:554-576.

2.      Cogo A, Romagnoli M, Ferrari M, Carati L, Ciaccia A. La N-acetilcisteina riduce la responsività bronchiale all’aerosol ipotonico in rinitici non asmatici. Giorn It Mal Tor 1998;52,4,303-310.

3.  Papi A, Corbetta L, Romagnoli M, Fabbri LM.  La terapia dell’asma nelle più recenti linee guida. Giorn It Allergol Immunol Clin (Ital J Allergy Clin Immunol)1998;8:46-4.

4.  Micaela Romagnoli, Leonardo Fabbri. Se l'asma diventa una malattia di difficile trattamento nell'adulto. In Ama Notizie, periodico dell'Associazione Malati Allergici della Regione Umbria aderente a FEDERASMA. Anno 4, numero 1, febbraio-marzo 2001, stampa tipografia Grifo, Perugia.

5.  M. Romagnoli, A. Papi, F. Luppi, LM Fabbri. New therapeutic indications for Cys-LT1 antagonists: chronic obstructive pulmonary disease. Clinical and Experimental Allergy Reviews, 2001, Vol.1, N°2:166-169.

6.  Micaela Romagnoli, Luca Richeldi, Leonardo Fabbri. Management of acute exacerbations of COPD. Leukotriene Research & Clinical Review. 2002, Vol.2, N°3:1-4.

7.  Fabrizio Luppi, Micaela Romagnoli, Leonardo Fabbri. Progetto Mondiale BPCO. Linee Guida per la diagnosi, prevenzione e trattamento della BPCO. In: BPCO Dimensione SNAMID. 2002 Gennaio-Febbraio, pgg.16-30.

8.  Micaela Romagnoli e Leonardo M Fabbri. Broncopneumopatia Cronica Ostruttiva: diagnosi e classificazione di gravità. Annali dell’Istituto Superiore di Sanità. 2003; 39(4):461-466.

9.  Leonardo Fabbri, Micaela Romagnoli, Stefania Cossi, Vittorio Grassi. Broncopneumopatia Cronica Ostruttiva: una breve rassegna. Ann Ital Med Int 2003;18:219-230.

10.  Romagnoli M, Fabbri LM. Chronic obstructive pulmonary disease: definition and classification of severity. Ann Ist Super Sanità. 2003;39(4):461-6.

11.  Micaela Romagnoli. La gestione ambulatoriale della Broncopneumopatia Cronica Ostruttiva. Ed. Time Science. 2004.

12.  Enrico Clini, Micaela Romagnoli. Asma bronchiale e Broncopneumopatia Cronica Ostruttiva (BPCO): analogie e differenze nella genetica, nella clinica e nella terapia. Asma & Allergia, 2003

13. Clini E, Romagnoli M. Self-management and healthcare utilisation in chronic obstructive pulmonary disease patients. Eur Respir Top 2004; 10: (vol.3).

14.  M Romagnoli, E Clini, LM Fabbri. Fixed airflow limitation caused by COPD or asthma: from definition to management. Med Hypotheses Res 2004;1:101-110.

15.  Clini E, Costi S, Romagnoli M, Florini F. Rehabilitation of COPD patients: which training modality. Monaldi Arch Chest Dis. 2004 Jul-Sep;61(3):167

16. E. Clini, M Romagnoli. Self-management and healthcare utilisation in COPD patients. Breathe 2004; vol.1, No 1:52.

17.  M Romagnoli, E Clini. A multidimensional grading system to predict outcome in COPD patients. Breathe 2004;vol.1, No 2:152.

18.  M Romagnoli, F Luppi, L Corbetta, A Papi, LM Fabbri. Management of fixed airflow limitation caused by asthma or chronic obstructive pulmonary disease. Clin Exp All Rev 2004; 4:205-211.

19. E Clini, M Romagnoli. Early rehabilitation in COPD patients admitted for acute exacerbation. Breathe, 2005;vol.1, No 3:245.

20. EM Clini, M Romagnoli. Inpatient pulmonary rehabilitation: does it make sense? Chronic Respiratory Disease 2005; 2:43-46.

21. M Romagnoli, S.Tomassetti, E. Balestro, S. Calabro,  A. Dubini, S. Asioli, V. Poletti. Malattie Linfoproliferative del Polmone: dalle iperplasie polmonari linfoidi ai linfomi. Parte II: Malattie linfoproliferative neoplastiche del polmone. Rassegna di Patologia dell'Apparato Respiratorio, 2008.

22. Venerino Poletti, Micaela Romagnoli, Gianluca Casoni, Caterina Bigliazzi, Sara Tomassetti, Christian Gurioli, Androula Marinou, Gianni Marchi, Carlo Gurioli. Short report - La ecoendoscopia transesofagea nelle lesioni mediastiniche - il messaggio per gli Pneumologi: “in rebus dubis plurimum est audacia”. Rassegna di Patologia dell'Apparato Respiratorio 2009,24(3):120-123.  

 23. Micaela Romagnoli, Gian Luca Casoni, Sara Tomassetti, Venerino Poletti. Year in Review: Pneumopatie infiltrative diffuse. Rassegna di Patologia dell’Apparato Respiratorio 2010,25:72-73.

CAPITOLI DI LIBRI INTERNAZIONALI

1.    Romagnoli M, Papi A, Baraldo S, Fabbri LM. Difficult asthma and chronic obstructive    pulmonary disease (COPD): similarities and discrepancies. In: Holgate ST, Boushey HA, Fabbri LM, Difficult asthma, London, Martin Dunitz 1999, Chapter 10: 163-181.

2.     M. Romagnoli, L. Richeldi and LM Fabbri. Clinical Assessment of Asthma and COPD: Diagnosis. In Asthma and COPD. Eds Peter Barnes, Jeffrey Drazen, Stephen Rennard, Neil Thomson. Academic Press, London, 2002;chap.43:447-455.

3.  Fabbri LM, Romagnoli M, Richeldi L, Olivieri D. Asthma versus chronic obstructive pulmonary disease. In: Asthma. European Respiratory Monography. Chung F, Fabbri LM eds. Vol.8; monograph 23, 2003:195-210.

4.  Pauwels P, Fabbri LM, Romagnoli M, Barnes PJ. Long-term management of persistent asthma in adults. In: Asthma. European Respiratory Monography. Chung F, Fabbri LM eds. Vol.8; monograph 23, 2003:376-395.

ATTI DI CONGRESSI INTERNAZIONALI
 
1.     Cogo A, Legorini C, Grimaldi A, Romagnoli M, Ciaccia A. Increased vascular permeability in hypoxemic COPD patients. Am J Respir Crit Care Med 1996;153:A823. 1996 ALA/ATS International Conference. New Orleans, USA.
 
2.     Romagnoli M, Tarodo de la Fuente P, Vachier I, Godard Ph, Chanez P. Sputum induced eosinophils and ECP levels are correlated to activity of asthma. Eur Respir J 1997;10 (suppl):292s. 1997 ERS Annual Congress. Berlin, Germany.
 
3.     Romagnoli M, Vachier I, Chiappara G, Tarodo de la Fuente P, Vignola AM, Bousquet J, Chanez P. Cellular and biochemical characteristics in induced sputum of asthmatic patients of various severity. Eur Respir J 1997;10 (suppl):184s. 1997 ERS Annual Congress. Berlin, Germany.
 
4.     Ravenna F, Fugagnoli A, Pasquini C, Romagnoli M, Caramori G, Ciaccia A. Effect of supplemental oxygen on arterial oxygen saturation during routine fibreoptic bronchoscopy. Am J Respi Crit Care Med 1997;A910. 1997 ALA/ATS International Conference. San Francisco, CA, USA.
 
5.     Romagnoli M, Ray P, Chanez P, Hibon S, Proudhon H, Dusser D, Wallaert B, Prud’homme A, Vervloet D, Taytard A, Godard Ph, ARIA. Severity of asthm ais not changing over time: long term follow-up of asthmatics with an expert system. Am J Respir Crit Care Med 1997;155:A890. 1997 ALA/ATS International Conference. San Francisco, CA, USA.
 
6.     Tarodo de la Fuente P, Romagnoli M, Vachier I, Carlson L, Godard P, Bousquet J, Chanez P. Sputum eosinophil cationic protein levels (ECP) in steroid dependent asthma. Am J Respir Crit Care Med 1997;155:A886. 1997 ALA/ATS International Conference. San Francisco, CA, USA.
 
7.      Vachier I, Romagnoli M, Tarodo de la Fuente P, Bousquet J, Godard Ph, Chanez P. Sputum leukotrienes content in asthma. Am J Respir Crit Care Med 1998;157:A615. 1998 ALA/ATS International Conference. Chicago, IL, USA.
 
8.      Corbetta L, Caramori G, Cogo AL, Romagnoli M, Forini E, Mantovanini S, Papi A, Fabbri LM. Education plus GINA booklets, but not GINA booklets alone, improve the knowledge and management of asthma. Am J Respir Crit Care Med 1999;159:A241. 1999 ALA/ATS International Conference. San Diego, CA, USA.
 
9.     Papi A, Guzzinati I, Braccioni F, Romagnoli M, Baraldo S, Ciaccia A, Fabbri LM. Increased exhaled nitric oxide is associated with an increased bronchodilator response to inhaled salbutamol in COPD. Am J Respir Crit Care Med 1999;159:A525. 1999 ALA/ATS International Conference. San Diego, CA, USA.
 
10.  Saetta M, Baraldo S, Romagnoli M, Papi A, Turato G, Corbino L, Visentin A, Mapp CE, Maestrelli P, Ravenna F, Fabbri LM. Pathology of moderate-severe asthma requiring high dosages of inhaled steroids. Am J Respir Crit Care Med 1999;159:A701. 1999 ALA/ATS International Conference. San Diego, CA, USA.
 
11.  L Corbetta, L Benini, CA Guidoboni, M Romagnoli, E Massa, C Tonolli, A Panariello, LM Fabbri. Active screening of the population with respiratory questionnaire and spirometry increases the detection of asthma and COPD in general practice. Eur Respir J 1999;14 (suppl 30):340s(P2291). 1999 ERS Annual Congress, Madrid, Spain.
 
12.  A Papi, S Baraldo, F Braccioni, I Guzzinati, M Romagnoli, A Ciaccia, LM Fabbri. Increased exhaled nitric oxide is associated with an increased response to inhaled salbutamol but not with sputum eosinophils in COPD. Eur Respir J 1999;14 (suppl 30):220s(P1502). 1999 ERS Annual Congress, Madrid, Spain.
 
13.  Papi A, Romagnoli M, CM Bellettato, Baraldo S, Casoni GL, Ciaccia A, Fabbri LM. Increased sputum eosinophils and exhaled NO, but not increased airway hyperresponsiveness, in asthmatics with irreversible airflow limitation as compared to patients with COPD. Am J Respir Crit Care Med 2000;161(3):A812. 2000 ALA/ATS International Conference, Toronto, Ontario, Canada.
 
14.  A Papi, M Romagnoli, CM Bellettato, AL Cogo, A Zanin, G Turato, M Saetta, A Ciaccia, LM Fabbri. Pulmonary function and pathology in asthma and chronic obstructive pulmonary disease (COPD) with similar degree of irreversible airflow limitation. Eur Respir J 2000;16 (suppl 31):551s(3902). 2000 World Congress on Lung Health and 10th ERS Annual Congress. Florence, Italy.
 
15.  A Papi, CM Bellettato, A Zanin, M Romagnoli, GL Casoni, K Busljetic, G Turato, M Saetta and LM Fabbri. Airway inflammation in asthma and chronic obstructive pulmonary disease (COPD) with similar degree of irreversible airflow limitation. Am J Respir Crit Care Med 2001;163(5):A80. 2001 ALA/ATS International Conference, San Francisco, California, USA.
 
16.  Romagnoli M, Chanez P, Vachier I, Bellettato C, Maakel L, Casoni GL, Papi A, Sala A, Folco G, Bousquet J, Godard Ph, Fabbri LM. Urinary LTE4 increases during exacerbations of COPD in elderly.Am J Respir Crit Care Med 2001;163(5):A768. 2001 ALA/ATS International Conference, San Francisco, California, USA.
 
17.  ALCogo, A Papi, M Romagnoli, A Ciaccia, LM Fabbri. Gas exchange abnormalities are different in moderate- severe asthmatic and COPD subjects with similar degree of poorly reversible airflow limitation. Am J Respir Crit Care Med 2001;163(5):A919. 2001 ALA/ATS International Conference, San Francisco, California, USA
 
18.  Romagnoli M, Chanez P, Vachier I, Bellettato C, Meschiari E, Papi A, Fabbri LM. Characteristics of exacerbations of moderate-severe COPD. Am J Respir Crit Care Med 2002;165(8):A272. 2002 ALA/ATS International Conference, Atlanta, Georgia, USA.
 
19.  Romagnoli M, Ligabue G, Papi A, Chanez P, Bousquet J, Romagnoli R, and Fabbri LM. High Resolution Computed Tomography (HRCT) Of The Chest Is Different In Patients With Fixed Airflow Limitation Due To Smoking Or To Asthma. Am J Respir Crit Care Med 2002;165(8):B:5. 2002 ALA/ATS International Conference, Atlanta, Georgia, USA.
 
20.  P Casolari, G Caramori, C Bellettato, M Romagnoli, G Casoni, A Ciaccia, PJ Barnes, IM Adcock, LM Fabbri, A Papi. Differential activation of p65 protein in alveolar macrophages and neutrophils in COPD sputum: effect of exacerbation. Am J Respir Crit Care Med 2002;165(8):A597. 2002 ALA/ATS International Conference, Atlanta, Georgia, USA.
 
21.  M. Romagnoli, P. Chanez, I. Vachier, C. Chavis, S. Petruzzelli, A. Ciaccia, L.M. Fabbri. Leukotrienes in moderate-severe COPD. Am J Respir Crit Care Med 2003;167:A228. 2003 ALA/ATS International Conference, Seattle, Whashington, USA.
 
22.  Giuseppina Rossi, Micaela Romagnoli, Ludovico Trianni, Sasa Lucic, Letizia Guerzoni, Fabio Florini, Daniela Lugli, Enrico Clini.Length of comprehensive pulmonary rehabilitation and clinical efficacy in mild to moderate COPD outpatients. Am J Respir Crit Care Med 2004;169:A755. 2004 ALA/ATS International Conference, Orlando, Florida, USA.
 
23.  Romagnoli M, Braccioni F, Ravenna F, Ciaccia A, Fabbri LM, Papi A and the ENFUMOSA Study Group. Near Fatal Asthma and Severe Persistent Asthma: two different entities. Am J Respir Crit Care Med 2005; 2;A622. 2005 ALA/ATS International Conference, San Diego, California, USA.
 
24.  EM Clini, D Dell’Orso, M Romagnoli, G Cirelli, C Cilione, D Lugli. Usefulness of repeated Pulmonary Rehabilitation (PR) in severe and disabled COPD inpatients. Am J Respir Crit Care Med 2005; 2;A800. 2005 ALA/ATS International Conference, San Diego, California, USA.
 
25.  M. Romagnoli, M. Chilosi, C. Bigliazzi, A. Carloni, G. Casoni, M. Zompatori, V. Poletti. Diffuse Parenchymal Drug-Induced Lung Disease: Report of a series. Eur Respir J 2006; 2006 ERS Annual Congress, Munich, Germany.
 
26.  Micaela Romagnoli, Sara Tomassetti, Gianluca Casoni, Carlo Gurioli, Marco Chilosi, Angelo Carloni, Venerino Poletti. Idiopathic Non-Specific Interstitial Pneumonia (NSIP): is it an autoimmune clinical entity? Eur Respir J 2007; 2007 ERS Annual Congress, Stockholm, Sweden.
 
27.  S. Tomassetti, A. Carloni, M. Chilosi, M. Romagnoli, A. Maffe, S. Ungari, N. Sverzellati, S. Piciucchi, G. Casoni, C. Gurioli, Ch. Gurioli, A. Marinou, V. Poletti. Birt-Hogg-Dubè Sindrome, Report of Two Novel Mutations and a Rare Tumor of the Lung. Am J Respir Crit Care Med 2009;179:A4396. 2009 ALA/ATS International Conference, San Diego, California, USA

     28. Gurioli C., Romagnoli M., Casoni GL, Tomassetti S., Gurioli Ch, Ravaglia C., Serra L, Piciucchi S, Poletti V. EBUS-TBNA in mediastinal lymphadenopathy: an Italian case series. Eur Respir J 2009;P627;2009 ERS Annual Congress, Vienna, Austria.

     29. Gurioli C, Romagnoli M, G. Casoni, L. Serra, S. Piciucchi, V. Poletti.Endoscopic ultrasound-guided fine-needle aspiration (EUS-FNA) for the diagnosis of mediastinal adenopathy: an Italian experience.Eur Respir J 2009;4471;2009 ERS Annual Congress, Vienna, Austria.
     
     30. Romagnoli M, Nannini C, Piciucchi S, Girelli F, Bernardi S, Gurioli C, Casoni GL, Tomassetti S, Gavelli G, Carloni A, Chilosi M, Dubini A, Cantini F, Poletti V. Idiopathic Nonspecific Interstitial Pneumonia (NSIP): Early Lung Manifestation of an Autoimmune Disease? ATS/ALA International Meeting, May 14-19th 2010, New Orleans, Louisiana. Am J Respir Crit Care Med 2010;181:A6002.
     31. Romagnoli M, Ulivi P, Tesei A, Gurioli C, Arienti C, Chiadini E, Casoni GL, Zoli W, Poletti V. Assessment of K-ras and epidermal growth factor (EGFR) receptor mutation by transesophageal ultrasound-guided fine needle aspiration (EUS-FNA) in lung adenocarcinoma. ATS/ALA International Meeting, May 14-19th 2010, New Orleans, Louisiana. Am J Respir Crit Care Med 2010;181:A5138.

 

 

Ufficio WEB